Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pharmaceutical composition for the treatment of MCP-1 mediated inflammatory diseases

Pharmaceutical composition for the treatment of MCP-1 mediated inflammatory diseases

US Patent 9492542 · Granted Nov 15, 2016

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pharmaceutical composition for the treatment of pain2023
Combination of trazodone and gabapentin for the treatment of pain2020
3-aminocarbazole compound, pharmaceutical composition containing it and preparat2018
Tricyclic indazole compound, method of preparation and pharmaceutical compositio2017
1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of2016
3-aminocarbazole compound, pharmaceutical composition containing it and preparat2016
Tricyclic indazole compound, method of preparation and pharmaceutical compositio2015
Food formulation comprising glycogen2014
(Aza)indole derivative substituted in position 5, pharmaceutical composition com2014
Use of an indazolemethoxyalkanoic acid for reducing triglyceride, cholesterol an2014
Use of an indazolemethoxyalkanoic acid for reducing triglyceride, cholesterol an2014
1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of2014